Miscellaneous Notices




14 MAY THE NEW ZEALAND GAZETTE 2153

The Tribunal had to be satisfied that in relation to Maori broadcasting the successful applicant would have the ability both financial and otherwise to provide it.

The Tribunal declined the ABS application orally. The Chairman stated it did not need the evidence tendered nor the evidence ABS proposed should be made available to the Tribunal by other parties. The applicant has since asked for the reasons to be given in writing.

The Tribunal was surprised that this application should have been filed at that stage without warning but did not consider that was a reason for dismissing it. The Tribunal considered that the application was intended to place the applicant company in a special position vis-a-vis the Tribunal because it proposed a consideration in detail of a specific programming proposal to be implemented in a specific way as a basis for a possible condition relating to supply of autonomously produced Maori programmes to a TV warrant holder.

The Tribunal is not however convinced that it does not have the ability to arrive at its own conclusions if it needs to assess the cost of such programming in whatever form it might be considered.

The Tribunal is an expert body. It has also heard a great deal of evidence over a long period, some of which was concerned with the cost of television production. Maori programming is television production. It is not so different from other programme production that the Tribunal cannot arrive at reasonable estimates of the cost so far as it is necessary for these hearings.

The Tribunal is capable of assessing any additional costs that might arise if an autonomous structure were found to be desirable and of any additional costs because of language factors or the particular ways in which programmes would be made and any additional considerations in the production of ethnic programmes.

The Tribunal therefore concluded that it did not need the assistance of this evidence in addition to all the other evidence it had received to make an assessment both in relation to programme costs and to consider the effect on revenue of particular types of programming.

Co-opted Members

The co-opted members took part in the deliberations of the Tribunal but the decision, in accordance with the Act, is that of the permanent members.

B. H. SLANE, Chairman.


North Island Raspberry Marketing Committee Elections Notice

No. 4051

Pursuant to regulation 15(4) of the Raspberry Marketing Regulations 1979, notice is hereby given that the roll of those persons qualified to vote for the election of four producers’ representatives to the North Island Raspberry Marketing Committee will be open for inspection during ordinary office hours at the following places, viz.:

Ministry of Agriculture and Fisheries Head Office Wellington
Auckland Hamilton Hastings Masterton
Te Kuiti New Plymouth Hawera
Tauranga Stratford Palmerston North
Whakatane Levin
Te Awamutu Wanganui
Matamata Marton

The roll will be available for public inspection for a period of 7 days from 28 May 1987, during which period any person may lodge with the Returning Officer an objection in writing under his hand to any entry on the roll.

Nomination forms may be obtained on application to any of the above offices or from the Returning Officer, Ministry of Agriculture and Fisheries, P.O. Box 1654, Palmerston North, with whom nominations close not later than noon on the 8th day of July 1987.

Dated at Palmerston North this 7th day of April 1987.

A. W. OKE, Returning Officer.


Consent to the Distribution of a New Therapeutic Drug

Pursuant to section 12 of the Food and Drug Act 1969 and section 114 (3) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new therapeutic drug set out in the Schedule hereto:

SCHEDULE

Name of Drug Form Active Ingredients (as listed on label) Name of Manufacturer Address
Capozide 25/15 Tablet Captopril 25mg Hydrochlorothiazide 15mg ER Squibb & Sons Ltd. or ER Squibb & Sons Pty. Ltd. United Kingdom Australia
Capozide 25/25 Tablet Captopril 25mg Hydrochlorothiazide 25mg ER Squibb & Sons Ltd. or ER Squibb & Sons Pty. Ltd. United Kingdom Australia
Capozide 50/15 Tablet Captopril 50mg Hydrochlorothiazide 15mg ER Squibb & Sons Ltd. or ER Squibb & Sons Pty. Ltd. United Kingdom Australia
Capozide 50/25 Tablet Captopril 50mg Hydrochlorothiazide 25mg ER Squibb & Sons Ltd. or ER Squibb & Sons Pty. Ltd. United Kingdom Australia

Dated this 3rd day of May 1987.

MICHAEL BASSETT, Minister of Health.


Consent to the Distribution of a Changed Medicine

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine set out in the Schedule hereto:

SCHEDULE

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Guaiphenesin 1.20%w/v Liquid Coldrex Cough & Cold Liquid
Pseudoephedrine Hydrochloride 0.60%w/v Sterling Pharmaceuticals Ltd., New Zealand
Dextromethorphan Hydrobromide 0.20%w/v
Chlorpheniramine Maleate 0.04%w/v

Dated this 3rd day of May 1987.

MICHAEL BASSETT, Minister of Health.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1987, No 71


NZLII PDF NZ Gazette 1987, No 71





✨ LLM interpretation of page content

⚖️ Broadcasting Tribunal Decision No. 13/87 (continued from previous page)

⚖️ Justice & Law Enforcement
22 April 1987
Broadcasting, Television Warrants, Tribunal Ruling, Evidence, Māori Broadcasting
  • B. H. SLANE, Chairman

🌾 North Island Raspberry Marketing Committee Elections Notice

🌾 Primary Industries & Resources
7 April 1987
Elections, Raspberry Marketing Committee, Voting Roll, Nomination
  • A. W. OKE, Returning Officer

🏥 Consent to the Distribution of a New Therapeutic Drug

🏥 Health & Social Welfare
3 May 1987
Therapeutic Drug, Distribution, Capozide, Food and Drug Act
  • MICHAEL BASSETT, Minister of Health

🏥 Consent to the Distribution of a Changed Medicine

🏥 Health & Social Welfare
3 May 1987
Medicine, Distribution, Coldrex Cough & Cold Liquid, Medicines Act
  • MICHAEL BASSETT, Minister of Health